-
Misonix Announces Exclusive U.S. Distribution Agreement For Advanced Wound Care Product
Wednesday, June 1, 2011 - 4:01pm | 121Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications has announced a new five-year...
-
Syneron Medical Terminates Shareholder Rights Plan
Wednesday, June 1, 2011 - 10:41am | 67Syneron Medical Ltd. (NASDAQ: ELOS) today announced that its Board of Directors has terminated the shareholder rights plan, effective May 31, 2011. The shareholder rights plan was adopted on November 11, 2008 after a decline in the market price of Syneron's common stock to ensure that all Syneron...
-
Abiomed Announces Appointment of Paul G. Thomas to Board of Directors
Wednesday, June 1, 2011 - 8:03am | 146Abiomed, Inc. (NASDAQ: ABMD)today announced the appointment of Paul G. Thomas to the Company's Board of Directors. Currently, Mr. Thomas is Chief Executive Officer and Founder of Roka Bioscience, a company focused on the development and commercialization of molecular assays and is a Director of...
-
Duncan-Williams Reiterates Buy Rating On Exactech
Wednesday, June 1, 2011 - 7:40am | 121According to Duncan-Williams, Exactech (NASDAQ: EXAC) announced the launch of the Proliant Polyaxial Pedicle Screw System for orthopedic and neurosurgeons. Duncan-Williams said that it is encouraged by this product launch as it represents the first spinal system developed in-house by EXAC. EXAC...
-
Bovie Medical Corporation Announces Exclusive Agreement to Distribute Next Generation of Medical Lighting
Wednesday, June 1, 2011 - 7:01am | 158Bovie Medical Corporation (NYSE: BVX) today announced that it has entered into an exclusive agreement with Medical Illumination International, Inc. San Fernando, CA to bring a new generation of medical lighting to the medical community in the United States. This line of LED lights features a 4300...
-
Morgan Stanley Provides Color on Becton Dickinson, Equal-Weight
Tuesday, May 31, 2011 - 9:17am | 151Morgan Stanley provided color on Becton Dickinson (NYSE: BDX) after a meeting with the company's management. In a research report published today, Morgan Stanley stressed a mixed picture of strong sales growth in the developing countries and sluggish sales in the developed countries. In the report...
-
China North East Petroleum Announces Dismissal of Lawsuit
Tuesday, May 31, 2011 - 8:33am | 157China North East Petroleum Holdings Limited (NYSE: NEP), a leading independent oil producing and oilfield services company in Northern China, today announced that on Friday, May 27th, the Clerk of the United States District Court for the Southern District of New York entered Judgment dismissing the...
-
Benzinga's Top Downgrades
Tuesday, May 31, 2011 - 8:26am | 138Analysts at Argus downgraded Medtronic Inc (NYSE: MDT) from “hold” to “sell.” MDT's shares closed at $40.31 yesterday. Medtronic 's PEG ratio is 1.42. Analysts at JP Morgan downgraded TASER International Inc (NASDAQ: TASR) from “neutral” to “underweight.” TASR's shares closed at $4.65 yesterday....
-
Goldman Sachs PT Changes For 5/31
Tuesday, May 31, 2011 - 7:59am | 145Goldman Sachs has changed the price targets on the following companies: Affymetrix (NASDAQ: AFFX) from $4.50 to $5, Sell Bank of New York Mellon (NYSE: BK) from $30 to $29, Neutral Baxter International (NYSE: BAX) from $69 to $72, Buy CME Group (NASDAQ: CME) from $345 to $325, Neutral...
-
Goldman Sachs Raises Baxter Target from $69 to $72
Tuesday, May 31, 2011 - 7:28am | 28Goldman Sachs is raising its PT on shares of Baxter International Inc. (NYSE: BAX) from $69 to $72. Baxter closed Friday at $59.11.
-
UPDATE: J.P. Morgan Raises PT on C.R. Bard to $104
Tuesday, May 31, 2011 - 7:17am | 149J.P. Morgan is out with its report today on C.R. Bard (NYSE: BCR), raising its PT from $97 to $104. In a note to clients, J.P. Morgan writes, "We are raising our December 2011 price target to $104 from $97, with the new target based on 14.5x our CY12 EPS estimate (vs the prior 13.5x multiple)....
-
JP Morgan Raises PT On CR Bard To $104
Tuesday, May 31, 2011 - 6:04am | 27JP Morgan has raised the price target on CR Bard (NYSE: BCR) from $97 to $104 and maintains its Neutral rating.
-
Bacterin is a Biotech Heading Towards Profitability
Monday, May 30, 2011 - 12:05pm | 67The following is a guest post by a fellow investor (mobile guru) whose interest lie within the mobile space. In a previous article I had discussed Rockwell Medical Technologies (RMTI) and its potential movement based on a new drug approval as well as their potential inclusion into the Russell Index...
-
Bank of America Merrill Lynch Maintains Buy on St. Jude Medical
Friday, May 27, 2011 - 10:05am | 112Bank of America Merrill Lynch is out with its report today on St. Jude Medical (NYSE: STJ), maintaining Buy. In a note to clients, Bank of America Merrill Lynch writes, "STJ trades at no meaningful premium to the group despite what we view as a solidly superior growth outlook on the top and bottom...
-
A Peek Into The Market Before The Trading Starts
Friday, May 27, 2011 - 7:25am | 421Pre-open movers US stock futures are flat this morning, as investors are awaiting housing and consumer-sentiment data. Futures on the Dow Jones Industrial Average dropped 10 points to 12,399.00 and futures on the S&P 500 stock index rose 0.20 point to 1,326.70. Nasdaq 100 futures dropped 0.25...